- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06103604
Tympanic Thermometers Accuracy
The Diagnostic Accuracy and Precision of the Latest Generation Tympanic Thermometers in the Adult and Paediatric Population: Multicentre Cross-sectional Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The temperature measurement will be taken on each patient enrolled at a single time by the caregiver for that patient. As the measurements do not depend on which side they are taken, the most convenient side will be chosen. Each patient will only be included once
The research nurse will record the core temperature from the monitor on the CRF and, within the next 5 minutes, take the peripheral temperature with the tympanic thermometer three times in a row, recording all three values on the CRF. Subsequently a second operator will always take the temperature 3 times within 5 minutes of the gold standard measurement. The gold standard (reference tests), as indicated in the literature, can be either the thermometer inserted in the probe placed in the pulmonary artery, or the thermometer inserted in the bladder catheter or oesophageal probe, or directly a rectal thermometer.
Only the first tympanic measurement will then be used to assess accuracy against the gold standard. The other measurements above will only be evaluated for inter and intra reliability. The unit under study is therefore the individual patient at a precise point in time
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Alessandria, Italy, 15121
- ASO Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo
-
Bologna, Italy, 40136
- Istituto Ortopedico Rizzoli
-
Bologna, Italy, 40138
- Policlinico di S.Orsola Azienda Ospedaliero-Universitaria di Bologna
-
Firenze, Italy, 50139
- Azienda Ospedaliera Universitaria Meyer Istituto di Ricovero e Cura a Carattere Scientifico
-
Pavia, Italy, 27100
- Fondazione IRCCS Policlinico San Matteo
-
Trento, Italy, 38123
- APSS Trento
-
Verona, Italy, 37126
- Azienda Ospedaliera Universitaria Integrata di Verona
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Paediatric patients over the age of 4 months
- adults admitted to intensive care and resuscitation
- undergoing surgery who by current practice undergo invasive core temperature measurement
Exclusion Criteria:
- Patients with bilateral auricular inflammatory problems,
- patients who will not use the gold standard for clinical reasons,
- patients or legal guardians who do not consent to participate in the study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
in-patients requiring temperature monitoring
The patient at any age whose core temperature is monitored during hospitalisation
|
The patient whose core temperature is monitored during hospitalisation has his temperature at tympanic level taken once during the stay.
The research nurse will record the core temperature from the monitor on the CRF and, within the next 5 minutes, take the peripheral temperature with the tympanic thermometer three times in a row, recording all three values on the CRF.
Subsequently a second operator will always take the temperature 3 times within 5 minutes of the gold standard measurement.
Only the first tympanic measurement will then be used to assess accuracy against the gold standard.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure of Agreement
Time Frame: The temperature measurement will be taken on each patient enrolled up to 2 weeks
|
Measure of Agreement between the thermometer and the gold standard to be assessed by the Bland and Altman method.
|
The temperature measurement will be taken on each patient enrolled up to 2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
accuracy
Time Frame: The temperature measurement will be taken on each patient enrolled up to 2 weeks
|
sensitivity, specificity, predictive values, likelihood ratios
|
The temperature measurement will be taken on each patient enrolled up to 2 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 507/2023/Oss/IOR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fever
-
Centre Hospitalier Annecy GenevoisNot yet recruitingEmergency Call | Fever; Pediatric Fever Management; Parental AnxietyFrance
-
Karolinska InstitutetCompletedCrimean Congo Hemorrhagic FeverSweden
-
Meir Medical CenterCompleted
-
Chengdu Jinjiang Maternity and Child Health HospitalNot yet recruiting
-
Sanofi Pasteur, a Sanofi CompanyCompletedYellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
U.S. Army Medical Research and Development CommandBausch Health Americas, Inc.WithdrawnCrimean-Congo Hemorrhagic Fever | Lassa FeverGermany
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Liverpool School of Tropical MedicineMedical Research Council; MEDEX; Mologic LtdNot yet recruitingCrimean-Congo Haemorrhagic Fever
-
Sanofi Pasteur, a Sanofi CompanyUnited States Department of DefenseCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
Shaare Zedek Medical CenterCompleted
Clinical Trials on latest generation tympanic thermometer
-
NHS Greater Clyde and GlasgowThales GroupActive, not recruiting
-
ARC DevicesCork University HospitalCompleted
-
Fondazione Italiana Linfomi ONLUSUnknown
-
University Hospital, BrestNot yet recruiting
-
Universitätsklinikum Hamburg-EppendorfTerminated
-
Istanbul University - Cerrahpasa (IUC)Recruiting
-
Cambridge University Hospitals NHS Foundation TrustObstetric Anaesthetists' AssociationRecruitingAnesthesiaUnited Kingdom